The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4.
Kyung Hee HanNoh Hyun ParkJin Ju KimSun Mie KimHee Seung KimMaria LeeYong-Sang SongPublished in: Journal of gynecologic oncology (2020)
The discrimination power of tumor markers for ovarian cancer was different according to menopausal status. In predicting ovarian malignancy, ROMA was neither superior to HE4 in premenopausal women nor superior to CA 125 in postmenopausal women.